When and How to Conduct Health Technology Assessments for Biosimilars?
Newswise — Lawrenceville, NJ, USA—May 13, 2024—ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the publication of a report from the ISPOR Biosimilars Special Interest Group highlighting the need for clearer …